Di Nuzzo Private Wealth, Inc. Exact Sciences Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 11 shares of EXAS stock, worth $586. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 14
21.43%
Holding current value
$586
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$951 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$940 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$666 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$643 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$353 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.43B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...